Program Overview Day 2: The Forth Annual Advances in the Management of Hepatocellular Carcinoma: A Multidisciplinary Approach

The Third Annual Advances in the Management of Hepatocellular Carcinoma: A Multidisciplinary Approach This multidisciplinary program provides a comprehensive update on the diagnosis, screening, and management of primary liver malignancies, with a focus on hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and emerging applications in transplant oncology. Through expert-led lectures, case-based discussions, and panel sessions, the program emphasizes evolving epidemiology, novel biomarkers, immunotherapy, interventional and surgical approaches, and the role of transplantation in advanced liver and colorectal cancer metastases. Attendees will gain practical, evidence-based insights to support collaborative decision-making and optimize patient care across the continuum of liver cancer management.

 Learning Objectives:

• Understand current and emerging epidemiologic trends, risk factors, and disparities in hepatocellular carcinoma and cholangiocarcinoma, including implications for screening and early diagnosis.
• Identify appropriate diagnostic, medical, interventional, surgical, and transplant-based treatment strategies for liver malignancies using a multidisciplinary, patient-centered approach.
• Explain the evolving role of novel biomarkers, immunotherapy, liver-directed therapies, and transplant oncology in optimizing outcomes for patients with primary and metastatic liver cancers.

Target Audience

This program has been designed oncology providers, including surgeons, physicians, fellows, residents, nurse practitioners, and physician assistants who manage patients with hepatocellular carcinoma (HCC) across various clinical specialties including; general & transplant surgery, oncology, immunology, pulmonology, cardiology, gastroenterology, infectious disease, neuroscience & radiology. 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Columbia University Department of Surgery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.